Key result
Treatment with neutralizing anti-ANGPTL4 antibodies significantly accelerated lung recovery and improved lung tissue integrity in mice with influenza pneumonia.
Why the study?
Does targeting ANGPTL4 reduce pulmonary tissue leakiness and damage in influenza pneumonia?
Does targeting ANGPTL4 reduce pulmonary tissue leakiness and damage in influenza pneumonia?
Neutralizing ANGPTL4 accelerates lung recovery and reduces tissue damage in influenza pneumonia models, suggesting a potential therapeutic target.
May limit influenza lung injury if targeted; hypothesis-generating and requires clinical validation.
Excessive host inflammatory responses negatively impact disease outcomes in respiratory infection. Host-pathogen interactions during the infective phase of influenza are well studied, but little is known about the host's response during the repair stage. Here, we show that influenza infection stimulated the expression of angiopoietin-like 4 (ANGPTL4) via a direct IL6-STAT3-mediated mechanism. ANGPTL4 enhanced pulmonary tissue leakiness and exacerbated inflammation-induced lung damage. Treatment of infected mice with neutralizing anti-ANGPTL4 antibodies significantly accelerated lung recovery and improved lung tissue integrity. ANGPTL4-deficient mice also showed reduced lung damage and recovered faster from influenza infection when compared to their wild-type counterparts. Retrospective examination of human lung biopsy specimens from infection-induced pneumonia with tissue damage showed elevated expression of ANGPTL4 when compared to normal lung samples. These observations underscore the important role that ANGPTL4 plays in lung infection and damage and may facilitate future therapeutic strategies for the treatment of influenza pneumonia.
No takes yet. Share an insight, caveat, or question.
Li et al. (2015) studied Influenza pneumonia. anti-ANGPTL4 antibodies vs. Untreated/wild-type counterparts was evaluated on Pulmonary tissue leakiness and lung damage. Treatment with neutralizing anti-ANGPTL4 antibodies significantly accelerated lung recovery and improved lung tissue integrity in mice with influenza pneumonia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: